Literature DB >> 11692759

[Treatment of colovesical fistula: predictive factors of the maintenance of long-term digestion continuity].

O Cappèle1, M Scotté, B Songné, L Sibert, F Michot, P Ténière.   

Abstract

AIM OF THE STUDY: Colovesical fistulas (CVF) may occur in inflammatory or tumoral pelvic diseases. The aim of this study was to analyze the surgical management of patients with a CVF in order to define predictive factors of good results and long term digestive continuity. PATIENTS AND METHODS: From 1989 to 1999, this retrospective study included 37 patients, 19 men and 18 women, mean age: 69 years (range 37-93 years). Main etiologies were colonic diverticulitis (n = 22) in 60% of the patients, cancer (n = 6) in 16%, previous radiotherapy (n = 5) in 14%. Treatment was a diverting colostomy in 13 cases, a colectomy in 24 cases without diverting colostomy in 10 cases.
RESULTS: Overall postoperative mortality rate was 16%. With a mean follow-up of 47 months, digestive continuity was restored in 40% of the patients (100% in ASA 1 patients, 55% in ASA 2, 19% in ASA 3 and 0% in ASA 4).
CONCLUSIONS: Our study suggests that long term digestive continuity following surgical treatment of colovesical fistulas does not depend upon etiology or surgical treatment but mainly upon the patient's ASA score.

Entities:  

Mesh:

Year:  2001        PMID: 11692759     DOI: 10.1016/s0003-3944(01)00608-3

Source DB:  PubMed          Journal:  Ann Chir        ISSN: 0003-3944


  2 in total

Review 1.  Enterovesical fistulas: diagnosis and management.

Authors:  G Scozzari; A Arezzo; M Morino
Journal:  Tech Coloproctol       Date:  2010-07-09       Impact factor: 3.781

2.  Penetration of the sigmoid colon to the posterior uterine wall secondary to diverticulitis: a case report.

Authors:  Tomoyuki Akiyama; Masahiko Inamori; Takeshi Shimamura; Hiroshi Iida; Hiroki Endo; Koji Fujita; Masato Yoneda; Hirokazu Takahashi; Yasunobu Abe; Noritoshi Kobayashi; Kensuke Kubota; Hiroshi Kobayashi; Shoji Yamanaka; Yasushi Rino; Atsushi Nakajima
Journal:  J Med Case Rep       Date:  2009-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.